Oncology Archives | Page 2 of 3

The American Urological Association Advanced Practice Provider (APP) Membership Committee has named Mary Dunn, RN, MSN, OCN, NP-C, as the recipient of the 2021 APP of the Year Award. This award was established to recognize the contributions and accomplishments of APPs in the field of urology. This award is presented annually to an AUA APP Member in recognition of their strong leadership skills and outstanding patient care in the field of urology.

The UNC Integrated Translational Oncology Program (iTOP) training program focuses on training clinicians, basic scientists, and MD-PhD candidates in clinical/translational disease-based research.

Marjory Charlot, MD, MPH, MSc, published an essay in the Journal of Clinical Oncology that recounts an experience with racism that was directed towards her from a patient. In the essay, she points to the need for education that will help trainees and all providers address interpersonal racism.

Oncology team donates to MICU and 6 Bedtower staff

Outpatient Adult Oncology team raised $800 as a way to say thank you to MICU and 6 Bedtower staff at UNC Medical Center for all of their hard work during challenging COVID-19 pandemic.

Michael Meyers, MD, professor in the division of surgical oncology and director of the general surgery residency program, authored an editorial on his research into innovations in Surgical Techniques.

Blossom Damania, PhD, vice dean for research at the UNC School of Medicine, was the only member of the UNC-Chapel Hill community selected as one of 276 new members to the oldest honorary society in the United States.

Kate Westmoreland, MD, has been amazed and excited by a surge of support for her work to improve treatment for adolescents and young adults with Burkitt lymphoma in Malawi, a country in Sub-Saharan Africa where this type of blood cancer is more common and deadly than in the United States.

The National Cancer Institute has awarded a five-year grant of more than $2.2 million to UNC Lineberger’s Yuliya Pylayeva-Gupta, PhD, to support her research into the immune response in pancreatic cancer, one of the deadliest cancers.

SCHALL, the rehabilitative facility dog at the N.C. Cancer Hospital’s pediatric hematology oncology clinic, with a patient.

Lifting spirits and helping ease tension are the calling cards of SCHALL, the rehabilitative facility dog at the N.C. Cancer Hospital’s pediatric hematology oncology clinic.

Paul Godley, MD, PhD, MPP, UNC School of Medicine’s Vice Dean for Diversity and Inclusion, and the Rush S. Dickson Distinguished Professor of Hematology/Oncology in the Department of Medicine, passed away Sunday, March 31. The funeral service will be held Saturday, April 6.

Eve Van Buren chalked up her fatigue to her stressful lifestyle. Turns out she was suffering from Overactive Parathyroid Glands. Diagnosis and surgery at UNC gave relief to Van Buren.

UNC Lineberger's Yuliya Pylayeva-Gupta, PhD, and Rahul Mirlekar, PhD.

In the journal Cancer Immunology Research, scientists led by UNC Lineberger’s Yuliya Pylayeva-Gupta, PhD, revealed that a molecule called interleukin-35 plays a role in suppressing cancer-fighting immune cells in pancreatic cancer.

Category: Oncology

Dunn recognized as American Urological Association APP of the Year

T32 in UNC-iTOP: Accepting Applications

The Power in Our Hands: Addressing Racism in the Workplace

Outpatient Adult Oncology Team Shows ‘Random Act of Kindness’ to MICU, 6 Bedtower Staff

Meyers authors editorial in prestigious Journal of Clinical Oncology

Damania Elected to American Academy of Arts and Sciences

Backed by grant, fundraiser, Westmoreland to launch study to improve survival for teens with blood cancer in Malawi

NCI awards $2.2M to Pylayeva-Gupta to investigate immune responses in pancreatic cancer

Four paws, two handlers, one great comfort: SCHALL

Remembering Paul Godley, UNC School of Medicine Vice Dean for Diversity and Inclusion

Feeling Brain Fog? Overactive Parathyroid Glands Could be the Culprit

Researchers find potential key to unlocking the immune system in pancreatic cancer